메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025

SHANGHAI and HONG KONG, Oct. 27, 2025 -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that the latest preclinical data of ATG-201 (CD19 x CD3 TCE) were presented in a Poster Presentation at the 2025 American College of Rheumatology (ACR) Annual Meeting, taking place from October 24th to October 29th in
- 김갑성 기자
- 2025-10-27 09:00
Innovent's Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide in a Head-to-head Phase 3 Clinical Trial DREAMS-3

[ 메디채널 김갑성 기자 ] The proportion of participants achieving HbA1c < 7.0% and a ≥10% reduction in body weight from baseline was 48.0% in the mazdutide group and 21.0% in the semaglutide group DREAMS-3 is the world's first Phase 3 clinical trial of a GCG/GLP-1 dual receptor agonist to conduct a head-to-head comparison with semaglutide in diabetes treatment SAN FRANCISCO and SUZHOU, China, Oct. 27, 2025 -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for th
- 김갑성 기자
- 2025-10-27 08:00
Real-World Data Presented at TCT 2025 Demonstrates the EggNest™ Complete Radiation Protection System Significantly Reduces Radiation Exposure for the Entire Cath Lab Team

SAN FRANCISCO, Oct. 26, 2025 -- At the 2025 Transcatheter Cardiovascular Therapeutics® (TCT) Conference, Dr. Jarrod Frizzell of The Christ Hospital (Cincinnati, OH) presented real-world studies¹,² demonstrating that the EggNest™ Complete Radiation Protection System from Egg Medical, Inc. (Roseville, MN) dramatically reduces radiation exposure for all members of the interventional team — including physicians, nurses, and technologists — compared to traditional shielding methods. During X-ray–guided cardiovascular procedures, scatter radiation poses a well-documented occup
- 김갑성 기자
- 2025-10-27 01:00
WuXi AppTec Achieves Strong Double-Digit Growth in Revenue and Profit for Q1-Q3 2025 Backlog for Continuing Operations Up 41.2% YoY Further Raises 2025 Full-year Guidance

Q3 Total Revenue: RMB12.06 Billion, Up 15.3% YoY; Revenue from Continuing Operations[1] Reached RMB12.04 Billion, Up 19.7% YoY Q1-Q3 Total Revenue: RMB32.86 Billion, Up 18.6% YoY; Revenue from Continuing Operations Reached RMB32.45 Billion, Up 22.5% YoY Q1-Q3 Net Profit Attributable to Owners of the Company Reached RMB12.08 Billion[2], Up 84.8% YoY; Diluted Earnings per Share (EPS) of RMB4.21[3], Up 87.9% YoY Q1-Q3 Adjusted Non-IFRS Net Profit Attributable to the Owners of the Company Reached RMB10.54 Billion, Up 43.4% YoY;
- 김갑성 기자
- 2025-10-26 15:53
Indonesia's Legacy in the Global Vaccine Landscape, Bio Farma and DCVMN Strengthen Health Resilience Through Global Partnership

BANDUNG, Indonesia, Oct. 25, 2025 -- Through PT Bio Farma (Persero), Indonesia has played a strategic and sustained role in the Developing Countries Vaccine Manufacturers' Network (DCVMN), working to ensure equitable access to safe, high-quality, and affordable vaccines. Since DCVMN's founding in 2000, Bio Farma has been a key driver in advancing vaccine self-reliance and public health capacity in developing countries. Collaboration between Bio Farma and DCVMN has been established since the inception of the network. At the first DCVMN Annual General Meeting in Noordwijk in 2000
- 김갑성 기자
- 2025-10-25 18:52
MHTC WELCOMES ROYAL OMAN POLICE TO ENHANCE GOVERNMENT-TO-GOVERNMENT COOPERATION

KUALA LUMPUR, Malaysia, Oct. 25, 2025 -- Malaysia Healthcare Travel Council (MHTC) concluded a four-day familiarisation visit by senior Royal Oman Police (ROP) officials from 21 to 24 October 2025. The delegation, led by Brigadier Dr Naseer Al-Manthery, Director General of Medical Services for Security Services, visited leading Malaysian hospitals and patient facilitation centres to evaluate clinical capabilities and care coordination systems. The visit builds on government-to-government engagement between MHTC and ROP that began in January 2025, when both organisations first d
- 김갑성 기자
- 2025-10-25 17:04
Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement

[ 메디채널 김갑성 기자 ] The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch HANGZHOU, China, Oct. 25, 2025 -- Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as the "Company") today announced the successful completion of patient enrollment in the Cardiovalve TARGET study for Transcatheter Tricuspid Valve Replacement (TTVR), with a total of 150 patients enrolled. The completion of enrollment marks a major milestone toward European regulatory approval for Cardiovalve's Transcatheter Tricuspid Valve Re
- 김갑성 기자
- 2025-10-25 15:00
Breathe Easy This Fall: VARON Supports Respiratory Wellness During Seasonal Change

NEW YORK, Oct. 25, 2025 -- As cooler temperatures and shifting air quality arrive, many families notice changes in their breathing. Dry air, allergens, and sudden cold snaps can worsen conditions like asthma or COPD, making respiratory health a top priority during the season. To help address these seasonal challenges, VARON, a leading provider of affordable oxygen solutions, is reinforcing its commitment to respiratory wellness with both education and dependable oxygen therapy products. Through its innovative line of affordable oxygen solutions—including the Seren
- 김갑성 기자
- 2025-10-25 08:00
국제건선협회연맹(IFPA), 2025 세계 건선의 날 맞아 건선 도미노 효과 중단 촉구

IFPA, 건선과 정신건강의 밀접한 연관성 인식 및 그 파괴적인 파급효과 방지 위한 행동 촉구 스톡홀름, 2025년 10월 25일 -- 전 세계는 매년 10월 29일 '세계 건선의 날(World Psoriasis Day)'을 맞아 전 세계 6000만 명 이상의 건선 질환자와 연대해 건선에 대한 인식을 제고하고 있다. 올해 국제건선협회연맹(International Federation of Psoriasis Associations•IFPA)은 '도미노 효과를 멈추자(Stop the Domino Effect)'는 글로벌 캠페인을 시작한다. IFPA의 '도미노 효과를 멈추자' 캠페인은 정책 결정자, 의료 전문가, 일반 대중에게 건선이 단순한 피부 질환이 아니라 당뇨와 심혈관 질환부터 우울증에 이르기까지 연쇄적인 심각한 건강 문제를 유발하며 삶에 큰 변화를 미치는 심각한 전신 질환임을 인식해줄 것을 촉구한다. 이 캠페인은 따라서 통합적 치료와 조기 개입 및 전 세계적으로 평등한 치료 접근성이 시급히 필요하다는 점을 강조한다. IFPA는 각국 보건 당국에 건선을 국가 비전염성 질환(NCD) 전략에 포함시키고, 환자
- 김갑성 기자
- 2025-10-25 07:00
MindHYVE.ai™ and Prime Institute of Health Sciences (PIHS) Launch Landmark AI Partnership to Transform Education and Healthcare in Pakistan

ISLAMABAD, Oct. 25, 2025 -- MindHYVE.ai™, a global leader in agentic artificial intelligence and adaptive learning technologies, has announced a landmark partnership with the Prime Institute of Health Sciences (PIHS) in Islamabad, marking a defining milestone in Pakistan's AI transformation journey. This collaboration introduces a dual-sector AI deployment—bringing ArthurAI™ to the classrooms and ChironAI™ to the hospitals of PIHS—making it the first institution in Pakistan to integrate artificial intelligence at scale across both education and healthcare. Arthur
- 김갑성 기자
- 2025-10-25 02:18

이전

71 72 73 74 75 76 77 78 79 80

많이 본 기사

최근기사

2026-01-01_THU

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 01일 22시 40분